NOMIX
Price
$21.69
Change
+$0.25 (+1.17%)
Updated
Jan 30 closing price
Net Assets
2.12B
VIMSX
Price
$75.80
Change
+$0.94 (+1.26%)
Updated
Jan 30 closing price
Net Assets
176.87B
Ad is loading...

NOMIX vs VIMSX

Header iconNOMIX vs VIMSX Comparison
Open Charts NOMIX vs VIMSXBanner chart's image
Northern Mid Cap Index
Price$21.69
Change+$0.25 (+1.17%)
VolumeN/A
Net Assets2.12B
Vanguard Mid Cap Index Investor
Price$75.80
Change+$0.94 (+1.26%)
VolumeN/A
Net Assets176.87B
NOMIX vs VIMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NOMIX vs. VIMSX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NOMIX is a StrongBuy and VIMSX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 177B vs. NOMIX (2.12B). NOMIX pays higher dividends than VIMSX: NOMIX (1.47) vs VIMSX (1.38). NOMIX was incepted earlier than VIMSX: NOMIX (20 years) vs VIMSX (27 years). NOMIX (13.39) and VIMSX (13.00) have comparable annual turnover. NOMIX has a lower initial minimum investment than VIMSX: NOMIX (2500) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 19.95 vs. NOMIX (10.89). VIMSX return over 5 years is better than : 55.84 vs. NOMIX (21.75).
NOMIXVIMSXNOMIX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years27 years-
Gain YTD3.5753.87192%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets2.12B177B1%
Annual Yield % from dividends1.471.38106%
Returns for 1 year10.8919.9555%
Returns for 3 years2.5717.5115%
Returns for 5 years21.7555.8439%
Returns for 10 years38.95128.5230%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VBCVX15.780.17
+1.09%
VALIC Company I Systematic Value
KAUCX3.88N/A
N/A
Federated Hermes Kaufmann C
ETNHX34.73N/A
N/A
Eventide Healthcare & Life Sciences N
HSEIX12.81N/A
N/A
Hartford Small Cap Value I
EMOLX15.73N/A
N/A
Lord Abbett Emerging Markets Equity F3